Literature DB >> 14150002

PENTAZOCINE--A NEW NONADDICTING ANALGESIC. PRELIMINARY SINGLE-BLIND STUDY.

M SADOVE, R C BALAGOT, F N PECORA.   

Abstract

Entities:  

Keywords:  ANALGESICS AND ANTIPYRETICS; BLOOD PRESSURE; DRUG ADDICTION; INJECTIONS, INTRAMUSCULAR; PHARMACOLOGY; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; RESPIRATORY FUNCTION TESTS; TOXICOLOGIC REPORT

Mesh：

Substances：

Year:  1964        PMID： 14150002

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  7 in total

Review 1.  Pentazocine: a review of its pharmacological properties, therapeutic efficacy and dependence liability.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1973       Impact factor: 9.546

2.  Preliminary communications.

Authors:  C Stanciu; J R Bennett
Journal:  Br Med J       Date:  1974-02-23

3.  The metabolic response to pentazocine as a supplement to balanced anaesthesia for major abdominal surgery.

Authors:  A B Dobkin; J S Israel; P A Pieloch
Journal:  Can Anaesth Soc J       Date:  1970-09

4.  Attenuation of the vagolytic effect of atropine during high thoracic epidural anesthesia by heart rate fluctuation analysis.

Authors:  O Shimoda; T Kano; Y Ikuta; M Tashiro; R Nakayama; T Oda; T Morioka
Journal:  J Anesth       Date:  1995-03       Impact factor: 2.078

Review 5.  Strategies for Developing κ Opioid Receptor Agonists for the Treatment of Pain with Fewer Side Effects.

Authors:  Kelly F Paton; Diana V Atigari; Sophia Kaska; Thomas Prisinzano; Bronwyn M Kivell
Journal:  J Pharmacol Exp Ther       Date:  2020-09-10       Impact factor: 4.030

6.  Studies of pentazocine (WIN-20228). I. Evaluation as an analgesic in post-operative patients.

Authors:  R A Gordon; J H Moran
Journal:  Can Anaesth Soc J       Date:  1965-07

7.  "I'll Be Back": The Resurrection of Dezocine.

Authors:  Wayne E Childers; Magid A Abou-Gharbia
Journal:  ACS Med Chem Lett       Date:  2021-05-19       Impact factor: 4.632
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.